Trellus Health PLC has announced a six-month contract extension with Johnson & Johnson Health Care Systems to continue providing its Trellus Elevate™ digital platform for patients with inflammatory bowel disease. This extension, on the same economic terms as the initial January 2025 collaboration, was granted due to the achievement of key engagement and satisfaction metrics. The company also continues to expand its TrialSet™ vertical with partners like ICON plc and PSI Inc. for clinical trials with Takeda and Sanofi.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Trellus Health PLC - Contract Extension with Johnson & Johnson
Trellus Health PLC has announced a six-month contract extension with Johnson & Johnson Health Care Systems to continue providing its Trellus Elevate™ digital platform for patients with inflammatory bowel disease. This extension, on the same economic terms as the initial January 2025 collaboration, was granted due to the achievement of key engagement and satisfaction metrics. The company also continues to expand its TrialSet™ vertical with partners like ICON plc and PSI Inc. for clinical trials with Takeda and Sanofi.